A white-label GLP-1 brand is a weight loss company that runs entirely under your name. You own the brand, the pricing, and the patient relationships. A turn-key platform handles everything behind the scenes: the licensed provider network, compounding pharmacy fulfillment, and the patient signup flow. Patients never see the platform.
The model exists because demand has outrun infrastructure. More than 40% of American adults have obesity, according to data from the Centers for Disease Control and Prevention. The global GLP-1 market generated $58.40 billion in revenue in 2025 and is projected to reach $212.73 billion by 2035, a 13.8% compound annual growth rate, according to Precedence Research (July 2026). This guide covers how the model works, what you own, the revenue math, the compliance rules, and how to choose a platform partner.
What Is a White-Label GLP-1 Brand?
The clinical and operational machinery behind your name belongs to a turn-key platform: a licensed provider network that writes the prescriptions, compounding pharmacies that prepare the medication, and a signup flow that runs on your site. The addressable patient population in the United States runs into the tens of millions, and most of those people have not yet received treatment.
Who launches these brands? Med spa owners with treatment rooms and steady foot traffic, gym owners whose members are already working toward weight loss, estheticians and chiropractors with existing client bases, and entrepreneurs with online audiences. The people already walking through the door are the marketing channel, which is why this model produces revenue faster than a from-scratch direct-to-consumer brand.
Why Launch Under Your Own Brand Instead of Reselling Someone Else’s?
A referral commission pays you for patient volume. A brand pays you for patient ownership, and the two compound very differently.
Brand equity. Every patient you acquire under your own name increases the value of your business. A gym or med spa that offers “our weight loss program” becomes the place clients refer friends to, and each referral adds to an asset you control. Patients acquired under someone else’s brand add to their asset, not yours.
The patient relationship. Retention, not acquisition, is where GLP-1 revenue is made, and you can only control retention when the patient belongs to you. In a reseller model, the platform owns the patient record and the ongoing relationship. When you own the brand, you decide how patients are communicated with, how renewals are handled, and how problems are resolved.
Margin control. You set the pricing. Your costs are pass-through: the medication, the provider consult, and a monthly platform fee. Everything above those costs is yours. A commission model caps your upside at a percentage and never pays you for the brand you build.
Room to expand. Your brand can add adjacent programs to the same patient base, such as TRT, HRT, or a white-label peptide telehealth program. Each new program is another recurring revenue line on the same asset, served to patients who already trust your name.
Exit value. A branded, recurring-revenue patient base is a sellable asset. Referral commissions stop the day the relationship ends.
How Does a White-Label GLP-1 Business Actually Work?
The platform collapses what normally takes five or six vendors into one contract, and the patient experience reads as a single company from start to finish.
A patient finds your site and completes the signup under your brand, answering the same health history questions any weight loss clinic would ask. An automated screening checks the responses against disqualifying conditions, so people with contraindications are filtered out early. Patients who clear it are reviewed by a state-licensed provider from the platform’s network, who approves or rejects the application. Approved patients receive medication compounded by a licensed pharmacy and shipped directly to them, with refills coordinated through the same flow.
The split of responsibilities is what makes the model work for non-clinical owners:
- You handle marketing, brand, pricing, patient experience, and retention. These are the jobs that decide whether the business grows.
- The platform handles the licensed provider network, compounding pharmacy integration, the signup flow, fulfillment, and the compliance backbone.
Karpa’s white-label GLP-1 platform is built for exactly this split: the partner runs the brand and the business, and the platform runs the clinical and operational machinery. Full white-label means patients never see Karpa’s name anywhere in the experience.
Speed is the other reason the model works. A white-label launch goes live the same day, and setup takes about 20 minutes once your brand assets are ready. The industry norm is different: most telehealth platforms take 60 days or more to launch, and a custom build takes months. You are competing with direct-to-consumer brands like Hims and Ro for the same patients, and they have entire teams and a multi-year head start. Same-day launch is how a two-person operation stays in the race. The full step-by-step is covered in the GLP-1 weight loss business launch guide.
What Do You Need to Launch a White-Label GLP-1 Company?
You do not need a medical license, a clinic, a pharmacy relationship, or a development team. You need a brand, a marketing channel, a price, and a platform partner.
A brand name and identity. A name, a logo, and a few lines of copy are enough to start. Most owners use their existing business brand, which lets them market the program to the people they already serve rather than building an audience from zero.
A website or landing page. The signup flow lives on your site. A simple page that states the program, the price, and what patients should expect is sufficient. The platform provides the signup experience; your page is where it lives.
A marketing plan. The weight loss companies that grow quickly know exactly who their patients are and how to reach them: foot traffic for med spas, members for gyms, audiences for creators, and referral relationships for estheticians and chiropractors.
Patient pricing. You set it. Typical programs price between $250 and $500 per month, and the price is yours to change as the market evolves.
A platform partner. This is the decision that determines your costs, your compliance exposure, and your ability to exit later. It deserves more attention than any other item on this list.
The structure that makes this legal for a non-clinical owner is a management services model. Your company operates the business: marketing, sales, patient experience, and branding. All clinical decisions sit with state-licensed providers, either ones you bring or the platform’s licensed provider network. This is the same structure used by thousands of medical weight loss and wellness companies across the country.
DIY vs. White-Label: What the Launch Actually Takes
| Decision | Build it yourself | White-label platform |
|---|---|---|
| Time to launch | 3 to 6 months or more | Same day to under a week |
| Medical license | You must contract a prescribing provider yourself | Platform’s licensed provider network covers it |
| Vendor contracts | EHR, telehealth, pharmacy, compliance: 5 to 6 | One platform |
| Patient signup flow | Build or buy and configure | Included, runs under your brand |
| Pharmacy relationships | Negotiate with compounders yourself | Included via integrated compounding pharmacies |
| Regulatory monitoring | Yours to own | Platform maintains it |
| Brand and patients | Yours | Yours |
| Upfront cost | Development, legal, and compliance spend | Platform fee plus brand assets |
How Much Money Can a White-Label GLP-1 Brand Make?
GLP-1 is subscription revenue. The patient pays every month, and the economics are built on retention, not one-time transactions.
Most white-label brands price their program between $250 and $500 per month, with $399 a common midpoint. For context, brand-name semaglutide retails for $900 to $1,500 per month without insurance, while compounded versions typically cost patients $150 to $350 per month. The cash-pay channel exists because the brand-name versions are out of reach for most people.
On a white-label platform, your costs are pass-through. The medication typically runs $80 to $150 per patient per month for compounded formulations, and the provider consult costs a few dollars per patient per month when amortized across a prescription. Above those sits the monthly platform fee.
Run the math on a realistic example. Priced at $399 with $140 in pass-through costs, one patient nets about $250 per month. Twenty-five patients generate about $6,250 per month, and at a 12-month average retention that is roughly $75,000 in gross margin from the first cohort alone. Partners on Karpa’s platform typically reach 20 to 30 active patients in their first month, and the highest performers start much faster.
Retention is what makes the math compound. In the STEP 1 trial published in the New England Journal of Medicine, patients on semaglutide lost an average of about 15% of their body weight over 68 weeks. A follow-up found that patients who stopped the medication regained about two-thirds of the lost weight within a year. That combination makes patients reluctant to quit, which is why well-run programs hold patients past the 12-month mark. A patient who stays two years at $399 per month is worth nearly $10,000 in revenue.
For a deeper breakdown of per-patient economics, margins, and overhead, see the cash-pay revenue model for GLP-1 and peptide programs.
What Are the Compliance Requirements for a White-Label GLP-1 Company?
Compliance is the reason DIY launches stall and the reason your platform choice matters more than any other decision. The rules are stable at the structural level and evolving at the medication level.
Cash-pay operations. You collect payment directly from patients, and there are no insurance claims. That removes the billing complexity of insurance-based practice while keeping you fully inside prescribing law. Your pricing and refund policies should be clear, published, and consistent.
Prescribing. Every prescription must come from a state-licensed provider. Non-clinical owners use the platform’s licensed provider network, which covers all 50 states, so state-by-state coverage is handled for you. If you are a licensed provider yourself, you can prescribe under your own authority.
Compounding rules. Compounded semaglutide is legal, but its status is tied to FDA shortage determinations and is actively evolving. Your pharmacy partners must hold the right credentials, 503A or 503B, and stay current on the rules. See the 503A vs. 503B compounding pharmacy guide and the GLP-1 compounding regulations guide for the details. A serious platform has a contingency plan if the legal pathway changes.
Advertising. Google and Meta require LegitScript certification to run ads for prescription medications, including compounded GLP-1s, and payment processors hold the same standard. Ask your platform how certification is handled before you launch. The LegitScript certification guide walks through the requirement and the cost.
How Do You Choose a White-Label GLP-1 Platform?
Every white-label platform looks similar on a landing page. They differ on ownership, transparency, and what happens when you leave, and those differences decide whether you are building a business or renting one.
Brand ownership. Confirm that patients never see the platform’s name anywhere in the experience and that you own your domain, your brand assets, and the patient relationship.
Pharmacy quality. Ask which compounding pharmacies are integrated, what credentials they hold, and whether medication is priced at pass-through or marked up. The difference is your margin.
Provider network. Verify which states are covered and what the platform does when a state changes its prescribing rules.
Pricing transparency. Get the monthly platform fee and every pass-through cost in writing before you sign. Platforms that hide per-unit pharmacy markup are not the bargain they appear to be.
Offboarding. Ask what happens if you leave. If you do not keep your patient list and your brand, the lock-in is the real cost of the contract.
The full due diligence list, including questions on fees, pharmacy markup, and exit terms, is in the 15 questions to ask before choosing a turnkey GLP-1 or peptide platform.
A white-label GLP-1 brand is the fastest path to owning a piece of the fastest-growing market in medicine, without a medical license, a clinic, or a stack of vendor contracts. Brand it, price it, market it, and let the platform run the clinical and operational machinery. The companies being built today are the weight loss businesses of the next decade.
Book a call with Karpa Health to walk through the launch, or start with the full GLP-1 weight loss business launch guide.
